Human normal immunoglobulin (Biotest AG)

N/A

Report date: 2022/06/07 16:06:08

Base Information

Drug NameHuman normal immunoglobulin (Biotest AG)
Drug Alias NameImmunoglobulin G (Biotest AG)Immune globulin - BiotestIntratectBT-595
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBirth WeightInflammationImmunologic Deficiency Syndromes +[13] 
Global Approved IndicationsImmunologic Deficiency SyndromesAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryGermany
Original Approved Date2004/09/27
Country/TerritoryUnited StatesSwedenRussian Federation +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiotest Ag
China Registration ClassN/A

Develop Information

Active CompaniesRwth Aachen UniversityBiotest Ag
Inactive CompaniesFakultas Kedokteran, Universitas Indonesia
Active IndicationsImmunologic Deficiency SyndromesAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic +[8] 
Inactive IndicationsBirth WeightInflammationInfant, Newborn, Diseases +[5] 

Other Information

ATC CodeJ06BA
Related LinksN/A